ValueAct Capital — The Quiet Activists of Wall Street

ValueAct Capital is one of the most successful activist hedge funds in the world — but don't expect picket signs or hostile letters. Founded in 2000 by Jeff Ubben, ValueAct pioneered a style of "constructive activism" that works behind closed doors, building partnerships with management rather than waging public battles.

Today, under CEO Mason Morfit, ValueAct manages approximately $16 billion and continues to generate outsized returns through deep engagement with a concentrated portfolio of companies.

Quick Answer

ValueAct Capital is a San Francisco "constructive activist" hedge fund founded in 2000 by Jeff Ubben and now led by CEO Mason Morfit, managing ~$16 billion in a deliberately concentrated 13F book of just 15–25 positions held for 3–5 years. Rather than public battles, it builds relationships with management and takes board seats to drive operational and capital-allocation change — its Microsoft board seat (2014–2017) is credited with aiding Satya Nadella's turnaround. Past wins include Adobe, Salesforce and 21st Century Fox. With so few names each disclosed stake is high-conviction, but the 13F lags up to 45 days — a positioning signal, not investment advice.

---

Key Facts

Investment Philosophy

ValueAct's approach is fundamentally different from aggressive activists like Icahn or Elliott:

1. Constructive engagement — ValueAct typically builds relationships with management teams before taking board seats, working collaboratively rather than adversarially
2. Concentrated portfolio — the fund holds only 15–25 positions at any time, with deep conviction in each investment
3. Long-term holding periods — average holding period of 3–5 years, far longer than most hedge funds
4. Board representation — ValueAct frequently takes board seats to drive strategic change from the inside
5. Operational improvement focus — rather than financial engineering, the fund focuses on improving business operations, strategy, and capital allocation

Mason Morfit — The New Standard-Bearer

Mason Morfit became CEO of ValueAct in 2020 after Jeff Ubben departed to launch Spring Fund (an ESG-focused vehicle). Morfit had been with ValueAct since 2003 and was instrumental in many of the fund's biggest successes.

Key Facts About Morfit:

• Background: Stanford MBA, former investment banker
• Style: Low-profile, relationship-driven, deeply analytical
• Board seats: Has served on the boards of Microsoft, Salesforce, and other major companies
• Microsoft engagement: Morfit's board seat at Microsoft (2014–2017) is widely credited with helping catalyze the company's transformation under Satya Nadella
• Philosophy: Believes the best activism happens when management and investors are aligned on long-term value creation

Jeff Ubben — The Founder's Legacy

Jeff Ubben founded ValueAct in 2000 and built it into one of the most respected activist funds on Wall Street. His "constructive activism" approach became a model for the industry.

• Pioneer of constructive activism — Ubben demonstrated that working with companies produces better results than fighting them
• Notable successes: Valeant (early investment), Microsoft, Adobe, and dozens of others
• Departure: In 2020, Ubben left ValueAct to launch Inclusive Capital Partners (Spring Fund), focused on ESG and sustainability investing
• Legacy: The constructive approach he built continues to define ValueAct under Morfit

Notable Holdings and Strategy

ValueAct's concentrated portfolio typically features mid-to-large cap companies where the fund sees operational improvement potential:

Common Themes in the Portfolio:

• Technology companies undergoing strategic transitions
• Healthcare companies with undervalued pipelines or operational inefficiencies
• Financial services firms ripe for digital transformation
• Industrial companies with capital allocation opportunities

Historical Successes:

Historical Performance

ValueAct has been one of the top-performing activist funds since inception:

• Average annual return: ~15–17% net (since 2000)
• Outperformance vs. S&P 500: approximately 4–6% annually over its history
• 2022: Navigated the downturn better than most growth-oriented funds
• 2023–2024: Strong performance driven by technology and healthcare holdings
• Drawdowns: Relatively contained due to concentration in high-conviction positions with catalyst timelines

The fund's returns are particularly impressive given the low-turnover, concentrated approach — it demonstrates that deep engagement can compound wealth over time.

What Makes ValueAct Different From Other Activists?

Why Track ValueAct's Portfolio?

ValueAct's 13F filings are uniquely valuable for individual investors:

1. High conviction signals — with only 15–25 positions, every holding represents a strong thesis
2. Operational catalysts — ValueAct's involvement often precedes meaningful business improvements
3. Long time horizons — positions are held long enough for individual investors to benefit
4. Quality filter — the fund's deep due diligence process effectively screens for companies with improvement potential
5. Alignment with management — constructive engagement means the fund and management are typically pulling in the same direction

How to Use ValueAct's Filings

• New positions are especially significant — they signal a new activist thesis
• Increased stakes suggest growing conviction
• Board seat announcements (from proxy filings) are strong catalysts
• Position exits may signal the thesis has played out

---

Track ValueAct Capital's concentrated portfolio alongside other legendary funds with Freenance

---

Frequently Asked Questions (FAQ)

What is "constructive activism"?

Constructive activism means working collaboratively with a company's management and board to create value, rather than launching hostile campaigns or public battles. ValueAct typically builds relationships before seeking board representation, focusing on operational improvements and strategic changes that benefit all shareholders.

How is ValueAct different from Elliott Management or Carl Icahn?

While Elliott and Icahn often use aggressive tactics — public letters, proxy fights, hostile proposals — ValueAct works behind the scenes. The fund builds relationships with management, takes board seats by invitation, and focuses on long-term operational improvement rather than short-term financial engineering.

Can I invest in ValueAct Capital?

ValueAct is a private hedge fund available primarily to institutional investors and high-net-worth individuals. Minimum investments are typically in the millions. However, individual investors can follow the fund's 13F filings to understand their investment theses.

What was ValueAct's role in Microsoft's transformation?

Mason Morfit joined Microsoft's board in 2014 and is widely credited with helping catalyze the company's shift toward cloud computing under CEO Satya Nadella. ValueAct's engagement helped refocus Microsoft's strategy, contributing to one of the greatest corporate transformations in history.

Who founded ValueAct Capital and who leads it now?

ValueAct was founded in 2000 by Jeff Ubben, who pioneered the firm's "constructive activism" style. Ubben departed in 2020 to launch the ESG-focused Inclusive Capital Partners, and Mason Morfit — with the firm since 2003 — became CEO. Morfit had previously led several of ValueAct's most prominent engagements, including its Microsoft board seat.

How large is ValueAct Capital's portfolio?

ValueAct has historically managed around $16 billion, with a 13F equity book typically holding just 15 to 25 positions. That concentration means each disclosed name represents a meaningful, high-conviction stake rather than passive diversification. Exact AUM shifts with markets and is reported quarterly, so it is worth checking current disclosures for the latest figures.

Can retail investors access ValueAct Capital?

Retail investors generally cannot access ValueAct directly — it is a private fund aimed at institutions and high-net-worth individuals with minimums typically in the millions. However, based on public 13F filings you can study the large-cap companies ValueAct holds, keeping in mind those filings lag the fund's actual positioning by up to 45 days. None of this is a recommendation to buy any particular security.

Related Articles

• Pershing Square Capital — Bill Ackman's Fund Profile & 13F Portfolio
• Elliott Investment Management — Profile of Paul Singer's Activist Fund
• Third Point — Dan Loeb's Fund Profile & 13F Portfolio
• Icahn Enterprises — Carl Icahn's Fund Profile
• Berkshire Hathaway — Warren Buffett's Fund Profile & 13F Portfolio

FAQ

How concentrated is ValueAct Capital's 13F portfolio under Mason Morfit?

ValueAct typically reports only 15–25 positions across roughly $16B AUM, so each name represents a meaningful share of the book. That concentration means a single new filing entry signals a deliberate, high-conviction thesis rather than passive index exposure.

Why is ValueAct considered a "constructive" activist rather than a traditional one?

Constructive activism means ValueAct usually engages management privately, negotiates board representation, and pushes for operational and capital-allocation changes over multi-year horizons. That style contrasts with louder public campaigns and tends to produce slower, lower-volatility position changes in the 13F.

How much does the 13F lag the fund's actual positioning?

US 13F filings disclose long equity positions up to 45 days after each calendar quarter ends, so ValueAct's reported book is typically 1.5–4.5 months old. Any new stakes opened mid-quarter only become visible once the next filing is published, which limits how useful 13Fs are for short-term timing.

Who are the largest historical buyers and sellers in ValueAct-style activist plays?

Other constructive and event-driven funds — for example Pershing Square, Third Point, Trian, and select long-only managers — often appear alongside ValueAct in the same names once a thesis is public. When ValueAct exits or trims, you frequently see index providers and passive holders absorb the supply rather than other activists.

Does ValueAct's portfolio fit a dividend or a growth profile?

ValueAct targets undervalued large-caps where it sees operational and strategic upside, so the book leans toward total-return rather than pure dividend income. Some holdings pay meaningful dividends, but the core thesis is capital appreciation driven by board-level change. This is informational only and not investment advice.